KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $231.0 million.

  • Tenet Healthcare's Depreciation & Amortization (CF) rose 1968.91% to $231.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $863.0 million, marking a year-over-year increase of 550.12%. This contributed to the annual value of $863.0 million for FY2025, which is 550.12% up from last year.
  • As of Q4 2025, Tenet Healthcare's Depreciation & Amortization (CF) stood at $231.0 million, which was up 1968.91% from $218.0 million recorded in Q3 2025.
  • In the past 5 years, Tenet Healthcare's Depreciation & Amortization (CF) registered a high of $231.0 million during Q4 2025, and its lowest value of $193.0 million during Q4 2024.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $211.0 million (2021), whereas its average is $212.4 million.
  • In the last 5 years, Tenet Healthcare's Depreciation & Amortization (CF) tumbled by 1373.39% in 2021 and then surged by 1968.91% in 2025.
  • Over the past 5 years, Tenet Healthcare's Depreciation & Amortization (CF) (Quarter) stood at $201.0 million in 2021, then rose by 5.97% to $213.0 million in 2022, then rose by 1.41% to $216.0 million in 2023, then fell by 10.65% to $193.0 million in 2024, then increased by 19.69% to $231.0 million in 2025.
  • Its last three reported values are $231.0 million in Q4 2025, $218.0 million for Q3 2025, and $208.0 million during Q2 2025.